Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-072874

Chief Commercial Officer sold 24,531 shares at $0.93 ($22,814)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Piccina Cintia Chief Commercial Officer 2024-06-18 Sale −24,531 $0.93 $22,814 38,293 D
Open-market sales · 24,531 sh · avg $0.93 · $22,814
Loading xslF345X05/tm2417532-1_4seq1.xml…